Codrug: An efficient approach for drug optimization

被引：84

作者：

Das, N. ^{[1
]}

Dhanawat, M. ^{[1
]}

Dash, B. ^{[1
]}

Nagarwal, R. C. ^{[1
]}

Shrivastava, S. K. ^{[1
]}

机构：

[1] Banaras Hindu Univ, Inst Technol, Dept Pharmaceut, Varanasi 221005, Uttar Pradesh, India

来源：

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2010年 / 41卷 / 05期

关键词：

Codrug; Mutual prodrug; Drug delivery; MUTUAL PRODRUG; L-DOPA; IN-VITRO; PROLIFERATIVE VITREORETINOPATHY; 5-AMINOSALICYLIC ACID; CO-DRUG; PHARMACOLOGICAL EVALUATION; TRIAMCINOLONE ACETONIDE; URSODEOXYCHOLIC ACID; PARKINSONS-DISEASE;

D O I：

10.1016/j.ejps.2010.09.014

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Codrug or mutual prodrug is an approach where various effective drugs, which are associated with some drawbacks, can be modified by attaching with other drugs of same or different categories directly or via a linkage. More appropriately one can say combining two different pharmacophores with similar or different pharmacological activities elicit synergistic action or help to target the parent drug to specific site/organ/cells respectively. This approach is commonly used to improve physicochemical, biopharmaceutical and drug delivery properties of therapeutic agents. (C) 2010 Elsevier B.V. All rights reserved.

引用

页码：571 / 588

页数：18

共 95 条

[31]

Fukuhara A, 1996, CHIRALITY, V8, P494, DOI 10.1002/(SICI)1520-636X(1996)8:7<494::AID-CHIR6>3.0.CO

[32]

2-B

[33] RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].

GABRIEL, SE ;

JAAKKIMAINEN, L ;

BOMBARDIER, C .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796

[34] Design, synthesis, and evaluation of novel mutual prodrugs (Hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro [J].

Gediya, Laiji K. ;

Khandelwal, Aakanksha ;

Patel, Jyoti ;

Belosay, Aashvini ;

Sabnis, Gauri ;

Mehta, Jhalak ;

Purushottamachar, Puranik ;

Njar, Vincent C. O. .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3895-3904

[35] BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia [J].

Geffen, Yona ;

Nudelman, Abraham ;

Gil-Ad, Irit ;

Rephaeli, Ada ;

Huang, Mei ;

Savitsky, Kinneret ;

Klapper, Leah ;

Ilan, Winkler ;

Meltzer, Herbert Y. ;

Weizman, Abraham .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (01) :1-13

[36] SULTAMICILLIN IN THE TREATMENT OF SUPERFICIAL SKIN AND SOFT-TISSUE INFECTIONS IN CHILDREN [J].

GOLDFARB, J ;

ARONOFF, SC ;

JAFFE, A ;

REED, MD ;

BLUMER, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :663-664

[37] Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs [J].

Goto, M ;

Okamoto, Y ;

Yamamoto, M ;

Aki, H .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (12) :1711-1720

[38] Mechanisms of cancer drug resistance [J].

Gottesman, MM .

ANNUAL REVIEW OF MEDICINE, 2002, 53 :615-627

[39] Advances in the management of inflammatory bowel disease [J].

Grimpen, F. ;

Pavli, P. .

INTERNAL MEDICINE JOURNAL, 2010, 40 (04) :258-264

[40] Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6β-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents [J].

Hamad, Mohamed O. ;

Kiptoo, Paul K. ;

Stinchcomb, Audra L. ;

Crooks, Peter A. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (20) :7051-7061

← 1 2 3 4 5 6 7 8 9 10 →